Related Experiment Video
Updated: Nov 10, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Gastric Carcinoid: The Invisible Tumor!
Samyak Dhruv1, Shamsuddin Anwar1, Abhishek Polavarapu2
1Internal Medicine, Northwell Health, New York, USA.
Gastric carcinoid (GC) tumors, rare neuroendocrine tumors, are increasingly diagnosed. This case highlights GC identification in a random gastric biopsy, emphasizing thorough examination for diagnosis.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Neuroendocrine tumors (NET) of the stomach, known as gastric carcinoids (GC), originate from enterochromaffin-like (ECL) cells.
- GC are rare, predominantly affecting women over 50, with a recent upward trend in incidence.
- While often visible during endoscopy, a significant portion (25%) are intramucosal and difficult to detect.
Observation:
- Most gastric carcinoid tumors are visible lesions during endoscopic examination.
- A notable proportion of gastric carcinoids are intramucosal, posing diagnostic challenges via standard upper endoscopy.
- Complete gastric mapping with biopsies from antrum, body, and fundus is crucial for accurate diagnosis.
Findings:
- This report details a rare case of gastric carcinoid identified incidentally on a random gastric biopsy specimen.
- The findings underscore the importance of comprehensive histological evaluation, even from seemingly random biopsies.
- The case illustrates a diagnostic scenario where the tumor was not readily apparent on initial endoscopic visualization.
Implications:
- Highlights the necessity of systematic biopsy protocols in gastric evaluations to avoid missing subtle lesions.
- Emphasizes the role of histopathology in diagnosing challenging cases of gastric carcinoid.
- Suggests potential underdiagnosis of intramucosal gastric carcinoids due to limitations in endoscopic visualization.
More Related Videos
10:31Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma
Published on: August 9, 2016
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Related Concept Videos
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...